Does Inhaled Busedonide or Fluticasone Impair Adrenal Function?
NCT00560625 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2016-09-08
Summary
Inhaled corticosteroids are largely used in patients with asthma or chronic obstructive lung diseases. The purpose of this study is to determine if the use of inhaled corticosteroids is associated with suppression of endogenous cortisol production, as seen in patients treated with pharmacologic doses of oral or parenteral steroids.
Conditions
Sponsors & Collaborators
-
HaEmek Medical Center, Israel
lead OTHER
Principal Investigators
-
Avraham Ishay, MD · Endocrine Institute , Haemek Medical Center, Afula. 18101 Israel
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-05-31
- Primary Completion
- 2007-12-31
- Completion
- 2008-12-31
Countries
- Israel
Study Locations
More Related Trials
-
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
NCT01479621 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis
NCT01086410 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Mometasone Furoate/Formoterol Combination and Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids (P04139)
NCT00379288 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma
NCT02139644 ·Status: COMPLETED ·Phase: PHASE3
-
Steroids In Eosinophil Negative Asthma
NCT02066298 ·Status: COMPLETED ·Phase: PHASE3
-
Steroid Sparing Effect of Nasal Corticosteroid In Asthma And Rhinitis
NCT00903227 ·Status: COMPLETED ·Phase: PHASE4
-
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
NCT00576069 ·Status: RECRUITING
-
Dose Response Effects of Inhaled Fluticasone on Airway Effects of Hypertonic-saline in Asthma
NCT00606242 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
NCT01431950 ·Status: COMPLETED ·Phase: PHASE3
-
Study on the Effects of an AMP Challenge on Asthmatic Patients Following Treatment With Fluticasone Propionate
NCT00400855 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1)
NCT00424008 ·Status: COMPLETED ·Phase: PHASE3
-
Inhalation of Corticosteroids in Smoking and Non-smoking Asthmatics.
NCT01400906 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
NCT02980133 ·Status: COMPLETED ·Phase: PHASE3
-
A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients
NCT00453778 ·Status: COMPLETED ·Phase: PHASE4
-
No Resistance After Long Term Treatment SERETIDE
NCT00456313 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy and Tolerability of Beclomethasone Dipropionate/Formoterol Single Inhaler in Patients With Mild to Moderate Persistent Asthma
NCT00862264 ·Status: COMPLETED ·Phase: PHASE3
-
Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER)
NCT00395304 ·Status: COMPLETED ·Phase: PHASE3
-
A Dose-ranging Study of Fluticasone Furoate (FF)
NCT01563029 ·Status: COMPLETED ·Phase: PHASE2
-
Open-label, Safety and Efficacy Study of Pulmicort® Turbuhaler® in Japanese Children With Bronchial Asthma
NCT00504062 ·Status: COMPLETED ·Phase: PHASE3
-
Study Comparing Budesonide Hydrofluoroalkane (HFA) vs Chlorofluorocarbon (CFC) Pressurized Metered Dose Inhalers (pMDI) in Patients With Mild to Moderate Asthma
NCT00667992 ·Status: COMPLETED ·Phase: PHASE3
-
Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations
NCT02066129 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma.
NCT01686633 ·Status: COMPLETED ·Phase: PHASE3
-
Inhaled Steroid Treatment as Regular Therapy in Early Asthma
NCT00641914 ·Status: COMPLETED ·Phase: PHASE4
-
Observed Outcomes Associated With Fluticasone Propionate/Salmeterol Xinafoate or Inhaled Corticosteroids in Asthma Patients
NCT01431924 ·Status: COMPLETED
-
Knemometry Study to Compare the Systemic Safety of Flutiform pMDI, Fluticasone pMDI and Beclometasone Autohaler in Paediatric Subjects Aged 5 to Less Than 12 Years.
NCT02063139 ·Status: COMPLETED ·Phase: PHASE2